surmount-1 tirzepatide trial obesity without diabetes for the Maintenance of Body Weight Reduction: Rationale, Design, and Baseline Characteristics of SURMOUNT‐MAINTAIN - Horn - 2025 - Tirzepatide once weekly for the

These reactions are common as your body begins adjusting to the medication

Tirzepatide therapy may be used to address medically supervised weight reduction, obesity-related comorbidities, and longer-term weight maintenance in appropriately selected patients

The subsequent disclosure of tirzepatide's mechanism through preclinical and clinical studies provides compelling data, strongly indicating its pharmacological properties and affirming its effects on glycemic control

They may also contact their insurance company directly to ascertain coverage and benefits, Ali said.

The discontinuation rate of tirzepatide was relatively low

Lancet Diabetes Endocrinol